Inventories (Details) $ in Thousands |
3 Months Ended | 9 Months Ended | |
|---|---|---|---|
|
Feb. 28, 2021
USD ($)
item
|
Feb. 28, 2021
USD ($)
item
|
May 31, 2020
USD ($)
|
|
| Inventory [Line Items] | |||
| Number of batches not saleable | item | 1 | ||
| Inventory Write-down | $ 6,100 | ||
| Number of portions of Biologic License Application ("BLA") resubmitted | item | 2 | ||
| Raw materials | 29,004 | $ 29,004 | $ 19,147 |
| Work in progress | 64,533 | 64,533 | |
| Total | 93,537 | 93,537 | $ 19,147 |
| Bulk Drug Substance [Member] | |||
| Inventory [Line Items] | |||
| Work in progress | 34,900 | 34,900 | |
| Drug Products [Member] | |||
| Inventory [Line Items] | |||
| Work in progress | $ 29,600 | $ 29,600 |
| X | ||||||||||
- Definition The number of batches of inventory deemed not saleable, generating inventory write-down. No definition available.
|
| X | ||||||||||
- Definition The number of portions of Biologic License Application ("BLA") that have been resubmitted for approval. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|